Biosimilars in the Treatment of Retinal Disease in the United States

Biosimilars have recently emerged into the vitreoretinal pharmaceutical market. This review defines biosimilars, discusses the approval process, and reviews the benefits, risks, and controversies regarding biosimilars. This review also discusses ranibizumab biosimilars that have recently received Un...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Ophthalmic surgery, lasers & imaging retina. - 2013. - 54(2023), 6 vom: 05. Juni, Seite 362-366
1. Verfasser:	Vakharia, Priya S (VerfasserIn)
Weitere Verfasser:	Eichenbaum, David A, Baumal, Caroline R
Format:	Online-Aufsatz
Sprache:	English
Veröffentlicht:	2023
Zugriff auf das übergeordnete Werk:	Ophthalmic surgery, lasers & imaging retina
Schlagworte:	Review Journal Article Biosimilar Pharmaceuticals Ranibizumab ZL1R02VT79